Cel-Sci Corp. said last week that it has set its previouslyannounced unit offering at 900,000 units. Each unit willconsist of five shares of common stock and five warrants topurchase a share of common per warrant. The Alexandria, Va.-based developer of products to treat cancer, AIDS andweakened immune systems hopes to raise $9 million to $10million. Underwriter Kober Financial Corp. has an option topurchase an additional 135,000 units to cover overallotments.Cel-Sci stock (NASDAQ:CELI) closed Monday at $1.97, up 25cents
(c) 1997 American Health Consultants. All rights reserved.